Therapy of immune neuropathies with intravenous immunoglobulins
Autor(es): Gold Ralf,Kieseier Bernd C
Resumo: Autoimmune-mediated disorders belong to the main causes of neuropathies worldwide. During recent years much progress has been achieved in the understanding of the underlying pathomechanisms, associated with implications for therapeutic approaches. Here we will briefly review the pathogenesis and discuss treatment options of the Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, and neuropathies associated with paraproteinemias. In most of these disease entities intravenous immunoglobulins play a major role as effective and safe treatment options.
Palavras-Chave: Guillain-Barré syndrome; Chronic polyneuritis; Multifocal motor neuropathy
Imprenta: Journal of Neurology, v. 253, supl 5, p. V59-V63, 2006
Identificador do objeto digital: 10.1007/s00415-006-5008-9
Descritores: Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies ; Guillain-Barre Syndrome - Immunology
Data de publicação: 2006